Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1985 1
1986 1
1987 1
1988 1
1989 2
1990 1
1991 1
1992 3
1994 1
1997 1
2005 4
2006 4
2007 3
2008 1
2009 4
2010 2
2011 9
2012 6
2013 14
2014 13
2015 17
2016 9
2017 13
2018 8
2019 10
2020 17
2021 26
2022 16
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons N; ALMS Group. Dooley MA, et al. N Engl J Med. 2011 Nov 17;365(20):1886-95. doi: 10.1056/NEJMoa1014460. N Engl J Med. 2011. PMID: 22087680 Free article. Clinical Trial.
How Long to Treat with Denosumab.
Costa AG, Bilezikian JP. Costa AG, et al. Curr Osteoporos Rep. 2015 Dec;13(6):415-20. doi: 10.1007/s11914-015-0295-7. Curr Osteoporos Rep. 2015. PMID: 26474564 Review.
Bone markers and osteoporosis therapy.
Bandeira F, Costa AG, Soares Filho MA, Pimentel L, Lima L, Bilezikian JP. Bandeira F, et al. Among authors: costa ag. Arq Bras Endocrinol Metabol. 2014 Jul;58(5):504-13. doi: 10.1590/0004-2730000003384. Arq Bras Endocrinol Metabol. 2014. PMID: 25166041 Review.
Bone turnover markers in primary hyperparathyroidism.
Costa AG, Bilezikian JP. Costa AG, et al. J Clin Densitom. 2013 Jan-Mar;16(1):22-7. doi: 10.1016/j.jocd.2012.11.004. J Clin Densitom. 2013. PMID: 23374737 Free PMC article. Review.
Osteoporosis: what's new and on the horizon.
Silva BC, Costa AG, Cusano NE, Bilezikian JP. Silva BC, et al. Among authors: costa ag. Clin Obstet Gynecol. 2013 Dec;56(4):730-8. doi: 10.1097/GRF.0b013e3182a9ece0. Clin Obstet Gynecol. 2013. PMID: 24036482 Review.
γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends.
Barros MS, de Araújo ND, Magalhães-Gama F, Pereira Ribeiro TL, Alves Hanna FS, Tarragô AM, Malheiro A, Costa AG. Barros MS, et al. Among authors: costa ag. Front Immunol. 2021 Sep 22;12:729085. doi: 10.3389/fimmu.2021.729085. eCollection 2021. Front Immunol. 2021. PMID: 34630403 Free PMC article. Review.
Insights Regarding the Role of Inflammasomes in Leukemia: What Do We Know?
Alves-Hanna FS, Crespo-Neto JA, Nogueira GM, Pereira DS, Lima AB, Ribeiro TLP, Santos VGR, Fonseca JRF, Magalhães-Gama F, Sadahiro A, Costa AG. Alves-Hanna FS, et al. Among authors: costa ag. J Immunol Res. 2023 Aug 4;2023:5584492. doi: 10.1155/2023/5584492. eCollection 2023. J Immunol Res. 2023. PMID: 37577033 Free PMC article. Review.
197 results